Skin Analysis Australia’s Post

REGISTER NOW 📆 C-Path's Predictive Safety Testing Consortium is delighted to announce its second public workshop on evidentiary considerations for regulatory assessment and qualification of complex in vitro models - CIVMs.  Health authorities, academia professionals, model developers, and representatives from the pharmaceutical industry are encouraged to participate in this workshop. It offers a valuable platform for attendees to engage in discussions and deliberations regarding the evidentiary considerations essential for regulatory assessment and qualification of CIVMs. Through collaborative efforts, attendees will strive to reach a consensus on the standards and features necessary to enhance the performance of CIVMs as a reliable tool for drug development and regulatory assessment. The meeting agenda features sessions led by key opinion leaders, who will address general considerations for qualification. Additionally, interactive breakout sessions will concentrate on various organ systems and disease models. During these breakouts, participants will actively engage in discussions and deliberations to explore the evidentiary considerations crucial for regulatory assessment and qualification of complex in vitro models. Join us September 26 - 27, 2024 in Bethesda, Maryland. Register now: https://lnkd.in/gi355YrF #CPath #PSTC #CIVM #workshop #drugdevelopment #datasharing #regulatoryscience #collaboration #globalhealth

REGISTER NOW 📆 C-Path's Predictive Safety Testing Consortium is delighted to announce its second public workshop on evidentiary considerations for regulatory assessment and qualification of complex in vitro models - CIVMs.  Health authorities, academia professionals, model developers, and representatives from the pharmaceutical industry are encouraged to participate in this workshop. It offers a valuable platform for attendees to engage in discussions and deliberations regarding the evidentiary considerations essential for regulatory assessment and qualification of CIVMs. Through collaborative efforts, attendees will strive to reach a consensus on the standards and features necessary to enhance the performance of CIVMs as a reliable tool for drug development and regulatory assessment. The meeting agenda features sessions led by key opinion leaders, who will address general considerations for qualification. Additionally, interactive breakout sessions will concentrate on various organ systems and disease models. During these breakouts, participants will actively engage in discussions and deliberations to explore the evidentiary considerations crucial for regulatory assessment and qualification of complex in vitro models. Join us September 26 - 27, 2024 in Bethesda, Maryland. Register now: https://lnkd.in/gVrccegB #CPath #PSTC #CIVM #workshop #drugdevelopment #datasharing #regulatoryscience #collaboration #globalhealth

Want to know more about bioMérieux? 📖 Read the latest Annual Report and learn more on bioMérieux’s major achievements in 2023 and the main challenges facing the in vitro diagnostic sector! 👉 https://lnkd.in/eYUhE5X3

The in vitro diagnostics market is at a turning point – balancing cautious optimism with immense growth potential. In this blog, IQVIA MedTech’s Matt Stewart shares insider insights from our latest industry polls, highlighting where the biggest opportunities lie! Curious to see where IVD is headed? Find out here: https://bit.ly/4gviH9G #IVD #digitalhealthcare

Looking to improve your immunoassays? This white paper covers key steps in modern antibody development, from production to cell banking. Partnering with experts can accelerate your launch and enhance IVD capabilities. Download now to learn more! https://lnkd.in/eUqAdd34 #AntibodyDevelopment #IVD #Diagnostics

Enhance your assay and speed up your launch! Learn how partnering with an antibody production expert can improve your diagnostic assay and streamline manufacturing. Discover key steps in modern antibody development. Download today! #Diagnostics #IVD #AntibodyProduction

Cell-based assays are crucial for analyzing ADCs (Antibody-Drug Conjugates) at various stages of research and development. These assays provide valuable insights into the efficacy, specificity, and safety of ADCs in vitro. Here are some important cell-based assays used in ADC analysis. https://lnkd.in/ecrHfprh    #ScientistsEnablingScientist #ADC #Services #Bioprocess #Biomanufacturing #CellBasedAssays 

Want to know more about bioMérieux? Read the latest Annual Report and learn more on bioMérieux’s major achievements in 2023 and the main challenges facing the in vitro diagnostic sector! 📖 https://lnkd.in/d9_43JXr

In the field of In Vitro Diagnostics (IVDs), ensuring that a new or modified test performs equivalently to an established method is crucial for accuracy and reliability. This process, known as method comparison, is a fundamental aspect of assay validation and regulatory compliance. This blog will discuss what method comparison entails, why it’s important, and how it’s typically conducted. Read more here: https://lnkd.in/ganmrAWh

𝗜𝗺𝗽𝗿𝗼𝘃𝗲 𝗮𝗻𝘁𝗶𝗯𝗼𝗱𝘆 𝗮𝗳𝗳𝗶𝗻𝗶𝘁𝘆 𝘁𝗼 𝗺𝗮𝘁𝗰𝗵 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗻𝗲𝗲𝗱𝘀 Have you ever invested a lot of time and money in your antibody discovery only to realize that your lead candidate lacks the required affinity to advance to clinical development? Let us optimize your antibody’s binding capabilities in just a few months -affinity maturation is one of #YUMAB’s core expertise!   Our client projects demonstrate KD fold-improvements by up to 10,000-fold to single-digit pM levels. Have a look at the data – Dr. Knowy below will show you the way 😉   Talk to one of our antibody engineering experts, Philipp Kuhn, about how we can improve the affinity of your antibody. Contact Philipp at p.kuhn@yumab.com     #DrugDiscovery, #Affinity, #Antibodies, #YUMAB